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ORIGINAL ARTICLEDetection of ST772 Panton-Valentine leukocidin-positive
methicillin-resistant Staphylococcus aureus (Bengal Bay clone) and ST22
S. aureus isolates with a genetic variant of elastin binding protein in NepalR. H. Pokhrel1, M. S. Aung4, B. Thapa1, R. Chaudhary2, S. K. Mishra3, M. Kawaguchiya4, N. Urushibara4 and N. Kobayashi4
1) Genesis Laboratory and Research, 2) Nepal Army Institute of Health Sciences, 3) Institute of Medicine, Tribhuvan University, Kathmandu,
Nepal and 4) Sapporo Medical University, Sapporo, JapanAbstractGenetic characteristics were analysed for recent clinical isolates of methicillin-resistant and -susceptible Staphylococcus aureus (MRSA and
MSSA respectively) in Kathmandu, Nepal. MRSA isolates harbouring Panton-Valentine leukocidin (PVL) genes were classiﬁed into ST1,
ST22 and ST88 with SCCmec-IV and ST772 with SCCmec-V (Bengal Bay clone), while PVL-positive MSSA into ST22, ST30 and ST772.
ST22 isolates (PVL-positive MRSA and MSSA, PVL-negative MRSA) possessed a variant of elastin binding protein gene (ebpS) with an
internal deletion of 180 bp, which was similar to that reported for ST121 S. aureus previously outside Nepal. Phylogenetic analysis
indicated that the ebpS variant in ST22 might have occurred independently of ST121 strains. This is the ﬁrst report of ST772 PVL-
positive MRSA in Nepal and detection of the deletion variant of ebpS in ST22 S. aureus.
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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E-mail: nkobayas@sapmed.ac.jpIntroductionMethicillin-resistant Staphylococcus aureus (MRSA) is recognized
as one of the most common pathogens of both nosocomial and
community-acquired infections worldwide. As a feature distinct
from methicillin-susceptible S. aureus (MSSA), MRSA has a
transmissible genome element, staphylococcal cassette chro-
mosome mec (SCCmec), inserted in a speciﬁc site of the
chromosome. The SCCmec in MRSA has been differentiated
into at least 12 genetic types (I–XII) [1,2], among which types
I– III have been traditionally associated with hospital-acquired
MRSA (HA-MRSA), while type IV and V have been commonly
found in community-acquired MRSA (CA-MRSA) [3]. However,w Microbe and New Infect 2016; 11: 20–27
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p://dx.doi.org/10.1016/j.nmni.2016.02.001in recent years, CA-MRSA with the dominant SCCmec types
(IV and V) has been brought to healthcare settings causing
nosocomial infections [4–6], which makes distinction between
HA- and CA-MRSA more difﬁcult in terms of SCCmec type.
The pathogenesis of many CA-MRSA strains have been attrib-
uted to the production of Panton-Valentine leukocidin (PVL), a
two-component toxin encoded by two genes, lukF-PV and luk-S-
PV, which are carried on lysogenic bacteriophages [7,8]. The
PVL causes leukocyte lysis or apoptosis via pore formation [9].
Accordingly, PVL-positive S. aureus is associated with severe
symptoms in a wide spectrum of infections including skin and
soft tissue infections and necrotizing pneumonia [10,11].
Prevalence of CA-MRSA harbouring PVL genes has been
increasing recently in hospitalized patients as well as healthy
individuals in the community [12,13].
Distribution and spread of MRSA clones on a global scale
have been revealed by genetic classiﬁcations with multilocus
sequence typing and SCCmec typing [14,15]. Several HA-MRSA
clones including ST5-MRSA-SCCmec II (ST5-II, NY/Japan clone)
and ST22-IV (EMRSA-15) are known as pandemic clonesEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Frequency of staphylocoagulase (coa) genotypes and
SCCmec types in Staphylococcus aureus isolates
Genotype
MRSA MSSA
PVL(+) PVL(−) PVL(+) PVL(−)
(n [ 25) (n [ 7) (n [ 48) (n [ 20)
coa
IIa 1 1 2 12
IIIa 2 0 0 1
IVa 1 0 26 0
Va 0 1 5 3
VIa 16 3 6 0
VIc 0 0 0 1
VIIa 2 0 2 2
VIIb 0 0 0 1
Xa 0 0 1 0
XIa 3 2 6 0
SCCmec
IV 1 1
V 17 3
NIa 7 3
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible
S. aureus; PVL, Panton-Valentine leukocidin.
aNot identiﬁed. Ten SCCmec-NI strains: two isolates, mec class untypeable
(mec-UT)/ccrA2B2; three isolates, mec-UT/ccrC1; three isolates, mec C2/ccr-UT;
two isolates, mec-UT/ccr-UT.
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respectively. In contrast, various clones have been documented
for CA-MRSA which are distributed locally or predominate in a
region, often associated with international spread. Globally
predominant CA-MRSA includes ﬁve clones, i.e. ST1 (USA400
clone), ST8 (USA300 clone), ST30 (South West Paciﬁc clone),
ST59 (Taiwan clone) and ST80 (European clone), among which
ST8 and ST30 are considered pandemic as a result of its dis-
tribution to every continent [15]. In Asia, two pandemic HA-
MRSA clones with ST5 and ST239 are disseminating, whereas
various CA-MRSA clones including those with ST8, ST30, ST59,
ST72 and ST772 have been reported [16].TABLE 2. Genetic characteristics and virulence factors in 17 Staph
mecA/PVL Isolate no.
Isolate
source
Genotype
Leukocidins,
haemolysinsaSCCmec coa agr ST
mecA NP154 Urine V IIa III ST1 lukE-lukD, hla, hld, hlg2
mecA NP177 Pus IV XIa I ST22 hla, hld
mecA NP18 Urine V VIa II ST772 hla, hld, hlg2
mecA/PVL NP160 Pus V VIa II ST772 lukE-lukD, hla, hlg2
mecA/PVL NP171 Blood V VIa II ST772 lukE-lukD, hla, hlg2
mecA/PVL NP173 Pus IV XIa I ST22 lukE-lukD, hla
mecA/PVL NP185 Pus V VIa II ST772 lukE-lukD, hla, hlg2
mecA/PVL NP189 Urine V VIa II ST772 lukE-lukD, hla, hlg2
mecA/PVL NP190 Pus V VIIa III ST1 lukE-lukD, hla, hld, hlg2
mecA/PVL NP27 Pus V IIIa III ST88 lukE-lukD, hla, hld, hlg2
PVL NP163 Pus IVa III ST30 lukE-lukD, hla
PVL NP169 Pus IVa III ST30 hla, hld
PVL NP172 Pus XIa I ST22 lukE-lukD
PVL NP166 Pus VIa II ST772 lukE-lukD, hlg2
PVL NP193 Pus VIa II ST772 lukE-lukD, hla, hlg2
PVL NP199 Urine XIa I ST22 lukE-lukD, hla
— NP195 Pus IIa I ST672 lukE-lukD, hla, hld, hlg2
aThe following genes were detected in all strains: hlg, icaA, icaD, eno, fnbB, clfA, clfB, sdrC.
bThe following genes were not detected in any strain: seb, see, sej, ser, ses, set, eta, etb, etd, e
cElastin binding protein gene (ebpS) with internal deletion (180 bp).
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in hospitals has been described to be 26–69% in several
studies via antimicrobial susceptibility testing [17–21],
although the rate varies depending on the types of infections
or specimens examined. A recent study revealed a high
prevalence of PVL genes in nosocomial isolates of MRSA and
MSSA (26% and 52% respectively) [22]. However, in Nepal,
there have been no studies conducted on genotypes (ST and
SCCmec types) of clinical MRSA isolates, particularly PVL-
positive isolates.
We analysed recent clinical isolates of MRSA and MSSA in
hospitals in Nepal. We found high prevalence of PVL in MRSA
and MSSA, as well as the presence of PVL-positive ST772
MRSA-V (Bengal Bay clone). A deletion variant of elastin binding
protein gene was ﬁrst identiﬁed in ST22 S. aureus isolates and its
origin was analysed.Materials and MethodsBacterial isolates and initial genetic analysis
From August 2012 to October 2012, about 200 S. aureus
isolates were collected from two general hospitals (approxi-
mately 100 isolates each) with more than 500 beds in Kath-
mandu, Nepal. These isolates were transported to Genesis
Laboratory and Research and processed. Of these, only 100
isolates recovered were included in this study. The main
specimen of the isolates was pus (n = 84), followed by urine
(n = 12), sputum and blood (n = 2 each). A single isolate from
each individual patient was subjected to study. Bacterial
isolation and species identiﬁcation were performed byylococcus aureus isolates in Nepal
Enterotoxinsb Adhesinsa,b,c Otherb
sea, sec, seh, sei, sek, sel, seq cna, ebpS, fnbA, ﬁb, sdrD, sdrE tst-1
sec, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS-v, fnbA, sdrD, sdrE chp, tst-1
sea, sec, seg, sei, sel, sem, sen, seo cna, ebpS, fnbA, ﬁb, sdrD, sdrE
sea, sec, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, ﬁb, sdrD, sdrE
sea, sec, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, ﬁb, sdrD, sdrE
sec, seg, seh, sei, sel, sem, sen, seo cna, ebpS-v, fnbA, sdrD, sdrE tst-1
sea, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, sdrD, sdrE
sea, sec, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, sdrD, sdrE
sea, seh, sek, sel, seq cna, ebpS, fnbA, ﬁb, sdrD, sdrE
sed, sek, seq ebpS, fnbA, ﬁb, sdrD, sdrE
seg, seh, sem, sen, seo, sep cna, ebpS, fnbA, bbp
seg, sem, sen, seo cna, ebpS, fnbA, ﬁb, bbp
seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS-v, fnbA, sdrD, sdrE
sea, sec, seg, seh, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, sdrD, sdrE
sea, seg, sei, sel, sem, sen, seo, sep cna, ebpS, fnbA, sdrD, sdrE
seg, sei, sem, sen, seo cna, ebpS-v, sdrD, sdrE
seg, sei, sem, seo ebpS, fnbA, ﬁb, sdrD, sdrE
din-A, edin-B, lukM, bnp, sak, scn.
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FIG. 2. Phylogenetic dendrogram based on nucleotide sequences of elastin binding protein genes (ebpS). Bootstrap values less than 80% are not
shown. Three lineages (I, II, III) and ST22 cluster are indicated at right. Closed circle indicates strains with ebpS-v (ebpS with internal 180 bp deletion).
Scale bar = 0.01 substitutions per nucleotide.
NMNI Pokhrel et al. ST772 and ST22 S. aureus in Nepal 23conventional microbiological methods, and the presence of
nuclease gene was conﬁrmed by multiplex PCR. Individual
bacterial strains were stored in Microbank (Pro-Lab Di-
agnostics, Richmond Hill, ON, Canada) at −80°C and recov-
ered when they were analysed.FIG. 1. Alignment of elastin binding protein (EbpS) amino acid sequences from
Amino acid numbers based on strain LG251 and CA-347 are shown above se
top; dash denotes gap. LBR near N terminus represents ligand-binding region o
indicates position of amino acid deletion detected in lineage II ebpS (see Fig.
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access artiStaphylococcal 16s rRNA, nuc, mecA, PVL gene (lukS-PV/lukF-
PV) and ACME-arcA (arginine deiminase gene) were detected
for all isolates by multiplex PCR assay as described by Zhang
et al. [23]. SCCmec type was determined by multiplex PCR
using previously published primers and conditions [24].13 Staphylococcus aureus isolates including three ST22 isolates in Nepal.
quence. Dot indicates identical amino acid to that of strain 71A_S11 on
f EbpS, and H1, H2 and H3 denote three hydrophobic domains. Asterisk
2).
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24 New Microbes and New Infections, Volume 11 Number C, May 2016 NMNIAntimicrobial susceptibility testing and detection of
drug resistance genes
Minimum inhibitory concentrations against 18 antimicrobial
agents based on the broth microdilution test were measured by
using Dry Plate ‘Eiken’ DP32 (Eiken Chemical, Tokyo, Japan).
Breakpoints deﬁned in the Clinical Laboratory Standards Insti-
tute guidelines were used to distinguish between resistant and
susceptible strains for most of drugs examined [25]. Antimi-
crobial resistance genes were detected by multiplex or uniplex
PCR using primers described previously [26].
Genetic typing, detection and analysis of virulence
factors
Staphylocoagulase genotype (coa type) of S. aureus isolates was
determined by multiplex PCR using previously published
primers and conditions [27]. For the strains for which the coa
types were not determined for I–X by the multiplex PCR,
partial coa sequences (D1, D2 and the central regions) were
determined as described previously [28,29] to assign the coa
genotype by sequence identity via BLAST search (http://blast.
ncbi.nlm.nih.gov/Blast.cgi). For selected isolates, sequence type
(ST) was determined according to the scheme of multilocus
sequence typing [30], and agr group was classiﬁed as described
previously [31].
Presence of genes encoding enterotoxins and other toxins,
adhesins, other proteins related to virulence and antimicrobial
resistance genes was analysed by multiplex or uniplex PCR
using primers described previously [26,32]. The sequence of
the gene encoding elastin binding protein (ebpS) was deter-
mined by PCR and direct sequencing, as described previously
[26]. Multiple alignment of ebpS sequences determined in the
present study and those retrieved from the GenBank database
was performed by the MultAlin interface (http://multalin.
toulouse.inra.fr/multalin/). The LALIGN program (European
Bioinformatics Institute; http://www.ebi.ac.uk/Tools/psa/lalign/
nucleotide.html) was used for pairwise alignment and calcula-
tion of identity between two ebpS sequences. A phylogenetic
tree of ebpS was constructed by the neighbour-joining method
by MEGA 5.01 software, statistically supported by boot-
strapping with 1000 replicates.
Full-length ebpS sequences of strains NP173, NP177 and
NP199 determined in the present study were deposited in the
GenBank database under accession numbers KT951674–
KT951676 respectively.Results and DiscussionAmong the 100 S. aureus clinical isolates examined, 32 isolates
were MRSA which had SCCmec type V (n = 20, 62.5%) or typeNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceIV (n = 2, 6.3%) (Table 1), while SCCmec type was not identiﬁed
for ten isolates. PVL genes were detected in 78% (25/32) of
MRSA and 71% (48/68) of MSSA isolates. The most common
coagulase genotypes of PVL-positive MSSA and MRSA were IVa
and VIa, respectively. Genetic characteristics were analysed for
17 isolates as representatives of PVL-positive MRSA (seven
isolates), PVL-positive MSSA (six isolates), PVL-negative MRSA
(three isolates) and a PVL-negative MSSA isolate (Table 2). The
PVL-positive MRSA isolates belonged to ST1, ST22, ST88 or
ST772. The ST772 was identiﬁed into MRSA with SCCmec V,
coa-VIa and agr-II (one PVL-negative and four PVL-positive iso-
lates), as well as two PVL-positive MSSA. ST22 was also iden-
tiﬁed in mecA-positive and/or PVL-positive isolates. MRSA
isolates with or without PVL were mostly resistant to ampicillin,
gentamicin and levoﬂoxacin, and had generally more drug
resistance genes than PVL-positive MSSA, although some mecA-
positive isolates (MRSA) were susceptible to oxacillin
(Supplementary Table S1). Although lukE-lukD and haemolysin
genes were detected in most isolates examined, ST772 isolates
(MRSA and MSSA) and ST22 MRSA had more enterotoxin genes
than ST1 and ST88 MRSA and ST30 MSSA isolates (Table 2).
In the present study, we ﬁrst demonstrated the presence of
ST772-MRSA-V and ST22-MRSA-IV in Nepal. ST772 and ST22
have been reported as epidemic clones associated with in-
fections in both community and healthcare settings in India
[16,33–35]. ST772 MSSA was originally reported in Bangladesh
[36]; thereafter, ST772-MRSA-V was identiﬁed in India, fol-
lowed by transmission to East/Southeast Asia, Australia, New
Zealand, the Middle East and Europe [15]. This clone is collo-
quially referred to as the Bengal Bay clone, and it is mostly PVL
positive and relatively multiresistant compared to other CA-
MRSA [37]. In addition to the increasing prevalence of
ST772-MRSA-V in India, detection of this clone outside India
has been related to travel history to or from India [14,37,38].
Because of its adjacent location, it is conceivable that ST772-
MRSA-V in India might have been readily transmitted to
Nepal, or it may have been originally endemic in Nepal as well
as India.
Although the elastin binding protein (EbpS) gene (ebpS) was
detected in all the isolates examined by PCR with primers
described previously [32], PCR products that were shorter
than the expected size (652 bp) were found in four ST22 iso-
lates (data not shown), among which three isolates (NP173,
NP177 and NP199; PVL-positive MRSA, PVL-negative MRSA
and PVL-positive MSSA respectively) were further analysed for
their ebpS gene sequences. These ebpS genes were revealed to
be a variant (ebpS-v) with an internal deletion of 180 bp
encoding a 60 aa sequence. By BLAST search, sequences similar
to ebpS-v were identiﬁed in strain 71A_S11 (ST22), 93b_S9 and
Y12 (ST121) and 6850 (ST50). Alignment of the deduced aminoEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 11, 20–27
nses/by-nc-nd/4.0/)
NMNI Pokhrel et al. ST772 and ST22 S. aureus in Nepal 25acid sequences of the ebpS-v identiﬁed in the present study with
those of other representative S. aureus strains is shown in Fig. 1.
The deleted portion (60 aa) of ebpS-v in ST22 Nepalese strains,
corresponding to aa 199–258 of EbpS from strain COL, was
identical to those found in strains 71A_S11, 93b_S9, Y12 and
6850 (GenBank accession nos. CP010940, CP010952, JF706229
and CP006706, respectively). Phylogenetic analysis of the ebpS
from various S. aureus strains, including ebpS-v, revealed the
presence of three major lineages (I, II and III) (Fig. 2). Lineage II
contained the ST22 cluster, which consisted of ebpS-v from
Nepalese strains and intact ebpS in ST22 strains as EMRSA-15.
In contrast, ebpS-v in ST121 strains clustered in lineage III.
Nucleotide sequence identity of intact ebpS within the same
lineage was more than 98.8%, while it was 95.2–98% between
different lineages (Supplementary Table S2). ebpS-v of ST22
Nepalese strains showed >99% identity with each other, but
slightly lower identity was found in ST121 strains (95.6–95.7%).
The variant of ebpS with a 180 bp deletion was ﬁrst reported
for isolates from orthopaedic infections in Italy, although their
ST was not identiﬁed [39]. Thereafter we identiﬁed a similar
ebpS variant (ebpS-v) in ST121 MSSA isolates in Myanmar [26]
as well as in ST121 isolates in Bangladesh [40] and Japan [41].
The present study elucidated that ebpS-v of ST22 and ST121
belong to different lineages, suggesting that the 180 bp deletion
event in ebpS might have occurred in ST22 S. aureus and ST121
S. aureus independently.
EbpS, one of the adhesins that binds to host cellular matrix
factors involved in bioﬁlm formation, is produced by most MRSA
examined so far [41–43]. EbpS is a cell-surface molecule and
mediates binding of bacterial cell to soluble elastin peptides and
tropoelastin [44,45], with its N-terminal region (aa 14–34) a
ligand-binding domain exposed on the surface of the cell and two
(H1 and H3) among the three putative hydrophobic domains
spanning the cell membrane [45]. Although the functional and
structural changes caused by the deletion in ST22 isolates are
unknown, the N-terminal region must be exposed on the surface
of cell for the normal function of ebpS-v; accordingly, theH2 region
is necessary to span the membrane instead of the deleted H1 re-
gion (Fig. 1, Supplementary Fig. S1). In that case, only the form of
the cytoplasmic portion of ebpS-v may be different from that of
EbpS, which may be possible to cause any functional difference.
It was notable in the present study that all the ST22 S. aureus,
including MRSA and MSSA, harboured ebpS-v, while intact ebpS
was also found in other previously reported ST22 strains
including EMRSA-15. In contrast, all the ST121 S. aureus ana-
lysed to date harboured ebpS-v [26,40,41]. The ST121 clone is
known to be a common cause of skin and soft tissue infection
disseminating globally, mostly mecA negative but PVL positive,
exhibiting higher virulence [46]. Although the association of
ebpS-v with the enhanced virulence of the ST121 clone is notNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behal
This is an open access artiknown, if the presence of ebpS-v affects phenotypic trait of
ST22 S. aureus (e.g. virulence or ﬁtness advantage to environ-
ment), it is possible that the proportions of ST22 isolates with
ebpS and ebpS-v may change over time epidemiologically.
Further studies thus may be necessary to monitor the preva-
lence of ST22 S. aureus with ebpS-v.AcknowledgementsThis study was supported by a Grant-in-Aid for Scientiﬁc
Research (KAKENHI, grant 26460804) from the Japan Society
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